Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 103 participants.

Also called NCT06520774

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 103 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06520774
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China, Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06520774. Allocation not applicable; no masking; primary purpose other. Start 2024-05-30 (actual); primary completion 2027-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
Condition
Aortic Arch Aneurysm
Condition
Penetrating Aortic Ulcer
Intervention (Device)
Concave Supra-arch Branched Stent-Graft System
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd. (class: industry)
Collaborator
Second Xiangya Hospital of Central South University (class: other)

Record details

Record id
cardio:ct-nct06520774
Content hash
ced9bb676c1725a61f05c7e6d55c568918431144951144e0c943b46cfd33b5ac